OMER
Omeros CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$632.20M
P/E Ratio
7.66
EPS
$1.14
Beta
2.53
52W High
$17.65
52W Low
$2.95
50-Day MA
$12.33
200-Day MA
$10.00
Dividend Yield
—
Profit Margin
871.00%
Forward P/E
58.14
PEG Ratio
0.81
About Omeros Corporation
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies, and orphan indications targeting inflammation, complement-mediated diseases, central nervous system (CNS) disorders, and system-related diseases. immunological. The company is headquartered in Seattle, Washington.
Fundamentals
| Revenue (TTM) | $9.89M |
| Gross Profit (TTM) | $-18.84M |
| EBITDA | $-104.33M |
| Operating Margin | -176.10% |
| Return on Equity | -576.00% |
| Return on Assets | -25.20% |
| Revenue/Share (TTM) | $0.15 |
| Book Value | $-0.88 |
| Price-to-Book | 8.44 |
| Price-to-Sales (TTM) | 63.90 |
| EV/Revenue | 75.84 |
| EV/EBITDA | -1.49 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.90% |
| Shares Outstanding | $72.38M |
| Float | $69.79M |
| % Insiders | 3.56% |
| % Institutions | 44.42% |
Historical Volatility
HV 10-Day
81.51%
HV 20-Day
69.83%
HV 30-Day
64.15%
HV 60-Day
70.46%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($40.00 target)
1
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026